M

MedinCell
MEDCL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€510.82M
EV
€541.16M
Shares Outstanding
33.33M
Beta
1.07

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€22.34
P/E 2025E
-
P/Revenue 2025E
27.39x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About MedinCell S.A.

gainify

M

MedinCell S.A.

MEDCL

MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The co...

Sector

Healthcare

Industry

Biotechnology

CEO

Douat, Christophe

Employees

131

IPO Date

2018-10-08

Headquarters

3 rue des FrEres LumiEre, Jacou, Languedoc-Roussillon, 34830, France

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.